aod9604 visceral fat AOD-9604 vs. Tesamorelin vs. Semaglutide: Body-Fat Research Guide How AOD-9604 Targets Fat Cells:

Compound structure-and-activity analysis

1 week (5 mg/day): ~1 vial 2 weeks (5 mg/day): ~1 vial 4 weeks (5 mg/day): ~2 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 1 week (once daily): ~7 syringes 1 week (BID): ~14 syringes 4 weeks (once daily): ~28 syringes Bacteriostatic Water (10 mL bottles) Use ~4.0 mL per 50 mg vial for reconstitution

There is no completed human evidence, and individual results are unknown

Though each method delivers nutrients directly to your bloodstream for enhanced vitamin utilization, an IV infusion also boosts your hydration and packs a greater punch than smaller vitamin shots

AOD-9604 was designed to retain the lipolytic activity of hGH without engaging the growth-hormone receptor in a way that elevates IGF-1